Sunday, 18 October 2009 14:41
The National Convention Asamsi-Famiglie SMA
The SMA National Conference organized by the Associations ASAMSI (Association for the Study of Childhood spinal muscular atrophies) and Famiglie SMA was held in Rome on 5 and 6 September.
SMA: Research, Rehabilitation and daily life is the title chosen for the 2009 edition of this event, which every year holds an increasing importance for the whole community of SMA families.
Interventions in the program were many and very important, such as to provide participants with the detailed updates on these three aspects - research, rehabilitation and daily life - which concern so closely the life of a person with SMA and his family.
Here is the list of those who have touched purely scientific arguments; for some are available the slides presented during the Conference.
Towards an international clinical trial: Outcome measures, EMEA and quality of life
E. Mercuri (Catholic University, Rome - Policlinico Gemelli, Rome - Imperial College, London)
Development of the stem cell therapy for the treatment of SMA
G. Comi (University of Milan)
New avenues of SMA I in Italy: NIV, PEG and… custom pediatric masks
G. Ottonello (Gaslini Hospital, Genova), I. Tognin (parent SMA)
Download slides
Scoliosis and breathing
M. Villanova (Clinic Nigrisoli, Bologna)
Clinical study to evaluate the tolerability and efficacy of salbutamol in adult patients with SMA III
L. Morandi (Istituto Besta, Milan)
The therapeutic trial with TRO19622 in SMA
E. Bertini (Ospedale Bambin Gesù, Rome)
Nutritional Management in spinal muscular atrophy
S. Messina (University of Messina – A.O.U. Policlinico di Messina)
Download slides
The news from the World Conference FSMA (USA)
D. Tiziano (Catholic University, Rome)
The Californian clinical trial with stem cells
T. Wyatt (University of California, Irvine)
Results and updates in the IPLEX study in SMA mice
F. Sangiuolo (University Tor Vergata, Rome)
Download slides
(sources: ASAMSI, Famiglie SMA)

This site is aimed at everyone involved in the fight against spinal muscular atrophy, whether patients and their families, physicians, health professionals or students of the area. The information in this site serves to enhance, not replace, the doctor-patient relationship.
Note on site manager
Note on sources
LAST UPDATE: July 25, 2010
No advertising on this site!
CAUTION Medical contents on the site are purely for guidance and information and cannot replace in any case the medical advice.
All contents provided by the site are written exclusively by professionals in the medical-scientific area, unless an explicit statement does not specify otherwise.- - Researchers demonstrate efficacy of antisense therapy for spinal muscular atrophy
- - Gene therapy rescues mice with SMA
- - Isis Pharmaceuticals towards an antisense drug
- - New finding clarifies the cause of SMA
- - Trans-splicing and gene therapy
- - Strengthening the junctions
- - New European funding for SMA research
- - New publications on SMA
This site complies with
the HONcode standard
for trustworthy health
information: verify here.


